Danilo Dias Avancini Viana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Danilo Dias Avancini Viana has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Elodie Bomfim Hyppolito
Universidade Federal do Ceará
3 shared publications - Gustavo Rêgo Coelho
Universidade Federal do Ceará
3 shared publications - Angel Evangelista Barroso Magalhães
Universidade Federal do Ceará
2 shared publications - Clébia Azevedo de Lima
Universidade Federal do Ceará
2 shared publications - Dayane Laura da Silva
Universidade Federal do Ceará
2 shared publications - José Huygens Parente Garcia
Universidade Federal do Ceará
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in Transplantation Proceedings
2,611 Liver Transplants: Indications and Survival Rates of a High-Volume Latin American Center
- 29 October 2026
- Published by Elsevier in Transplantation Proceedings
Open Access2,611 Liver Transplants: Indications and Survival Rates of a High-Volume Latin American Center
- Open Access
- 12 January 2024
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 27 (1)
Thyroid Metastases from Hepatocellular Carcinoma after Liver Transplantation
Hepatocellular carcinoma (HCC) patients with metastases to the thyroid are extremely rare. A patient who underwent liver transplantation for HCC recurrence had metastatic thyroid recurrence detected 4 years later. A literature review identi"ed six documented cases, analyzing relevant data on HCC with thyroid metastasis following liver transplantation. !ere is a prevalence of hepatitis B virus (HBV ) and hepatitis C virus (HCV ) as etiologies of liver disease (83.3%), with alpha-fetoprotein (AFP) levels elevated in "ve cases. Additionally, the time between the diagnosis of HCC and thyroid metastasis was within 3 years. !e patient remains clinically stable in outpatient follow-up, with an 8-month current survival after total thyroidectomy.
- 12 January 2024
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 27 (1)
Open AccessThyroid Metastases from Hepatocellular Carcinoma after Liver Transplantation
Hepatocellular carcinoma (HCC) patients with metastases to the thyroid are extremely rare. A patient who underwent liver transplantation for HCC recurrence had metastatic thyroid recurrence detected 4 years later. A literature review identi"ed six documented cases, analyzing relevant data on HCC with thyroid metastasis following liver transplantation. !ere is a prevalence of hepatitis B virus (HBV ) and hepatitis C virus (HCV ) as etiologies of liver disease (83.3%), with alpha-fetoprotein (AFP) levels elevated in "ve cases. Additionally, the time between the diagnosis of HCC and thyroid metastasis was within 3 years. !e patient remains clinically stable in outpatient follow-up, with an 8-month current survival after total thyroidectomy.
- Open Access
- 12 January 2024
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 27 (1)
Metástases Tireoidianas de Carcinoma Hepatocelular após Transplante Hepático
Pacientes com metástase tireoidiana de carcinoma hepatocelular (CHC) são extremamente raros. Um paciente que realizou transplante hepático devido à recorrência de CHC apresentou metástase tireoidiana detectada 4 anos depois. A revisão de literatura identificou seis casos documentados, analisando informações relevantes sobre CHC com metástase tireoidiana após transplante de fígado. Verificou-se a prevalência do vírus da hepatite B (VHB) e da hepatite C (VHC) como etiologias da doença hepática (83,3%), com níveis elevados de alfafetoproteína (AFP) em cinco casos. Além disso, o tempo entre o diagnóstico de CHC e a metástase tireoidiana foi inferior a 3 anos. O paciente permanece clinicamente estável no acompanhamento ambulatorial, com sobrevida atual de 8 meses após tireoidectomia total.
- 12 January 2024
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
- Vol. 27 (1)
Open AccessMetástases Tireoidianas de Carcinoma Hepatocelular após Transplante Hepático
Pacientes com metástase tireoidiana de carcinoma hepatocelular (CHC) são extremamente raros. Um paciente que realizou transplante hepático devido à recorrência de CHC apresentou metástase tireoidiana detectada 4 anos depois. A revisão de literatura identificou seis casos documentados, analisando informações relevantes sobre CHC com metástase tireoidiana após transplante de fígado. Verificou-se a prevalência do vírus da hepatite B (VHB) e da hepatite C (VHC) como etiologias da doença hepática (83,3%), com níveis elevados de alfafetoproteína (AFP) em cinco casos. Além disso, o tempo entre o diagnóstico de CHC e a metástase tireoidiana foi inferior a 3 anos. O paciente permanece clinicamente estável no acompanhamento ambulatorial, com sobrevida atual de 8 meses após tireoidectomia total.